These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 24926901

  • 1. Response rate and factors affecting the outcome of a fixed dose of RAI-131 therapy in Graves' disease: a 10-year Egyptian experience.
    El-Kareem MA, Derwish WA, Moustafa HM.
    Nucl Med Commun; 2014 Sep; 35(9):900-7. PubMed ID: 24926901
    [Abstract] [Full Text] [Related]

  • 2. Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs.
    Esfahani AF, Kakhki VR, Fallahi B, Eftekhari M, Beiki D, Saghari M, Takavar A.
    Hell J Nucl Med; 2005 Sep; 8(3):158-61. PubMed ID: 16390021
    [Abstract] [Full Text] [Related]

  • 3. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
    Metso S, Jaatinen P, Huhtala H, Luukkaala T, Oksala H, Salmi J.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early treatment with low fixed dose (5 mCi) radioiodine therapy is effective in Indian subjects with Graves' disease.
    Sanyal D, Mukhhopadhyay P, Pandit K, Chatterjee J, Raychaudhuri M, Mukherjee S, Chowdhury S.
    J Indian Med Assoc; 2008 Jun; 106(6):360-1, 372. PubMed ID: 18839646
    [Abstract] [Full Text] [Related]

  • 9. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
    Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
    [Abstract] [Full Text] [Related]

  • 10. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
    Hou H, Hu S, Fan R, Sun W, Zhang X, Tian M.
    Biomed Res Int; 2015 Aug; 2015():974689. PubMed ID: 25879041
    [Abstract] [Full Text] [Related]

  • 11. Analysis of ¹³¹I therapy and correlation factors of Graves' disease patients: a 4-year retrospective study.
    Zheng W, Jian T, Guizhi Z, Zhaowei M, Renfei W.
    Nucl Med Commun; 2012 Jan; 33(1):97-101. PubMed ID: 22008631
    [Abstract] [Full Text] [Related]

  • 12. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM, Shawkat W.
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Time course to hypothyroidism after fixed-dose radioablation therapy of Graves' disease in children.
    Nebesio TD, Siddiqui AR, Pescovitz OH, Eugster EA.
    J Pediatr; 2002 Jul; 141(1):99-103. PubMed ID: 12091858
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical exacerbation of preexisting Graves' disease induced by insufficient radioiodine treatment: a report of five patients.
    Lee SW, Lee J, Bae JH, Seo JH, Kang SM, Ahn BC, Lee I.
    Nucl Med Commun; 2009 Apr; 30(4):275-80. PubMed ID: 19252454
    [Abstract] [Full Text] [Related]

  • 16. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
    Mihailescu DV, Hoscheit C, Fogelfeld L.
    Endocr Pract; 2024 Apr; 30(4):333-339. PubMed ID: 38307459
    [Abstract] [Full Text] [Related]

  • 17. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D, Epstein M, Lan L, Tan P, Booker J.
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Personalization of radioiodine treatment for Graves' disease: a prospective, randomized study with a novel method for calculating the optimal 131I-iodide activity based on target reduction of thyroid mass.
    Orsini F, Traino AC, Grosso M, Guidoccio F, Boni G, Volterrani D, Mariani G.
    Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):496-502. PubMed ID: 23358401
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.